Filing Flows › Exagen (XGN) › Q4 2024
Exagen (XGN) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 11, 2025
Exagen (XGN) reported revenue of $13.7M for the fourth quarter 2024 (Q4 2024), -0.8% from a year earlier and +9% from the quarter before. Operating margin was -24.8%, net loss $3.8M (27.5% of revenue).
Exagen, Q4 2024: revenue $13.7M (-0.8% year over year), operating margin -24.8%, net loss $3.8M, operating cash flow $363K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.7M | +9% | -0.8% |
| Operating profit | −$3.4M | — | — |
| Net earnings | −$3.8M | — | — |
| Operating cash flow | $363K | — | -96% |
| Free cash flow | $217K | — | -97% |
What changed
Revenue was $13.7M in Q4 2024, down 1% year over year and up 9% from the previous quarter.
Gross margin was 62.1%. Operating costs exceeded revenue by $3.4M, an operating margin of -24.8%. The fastest-growing cost line was Research & development (+54%). The quarter ended with a net loss of $3.8M, narrower than the previous quarter's $5.0M loss.
Operating cash flow was $363K (down 96% year over year). Non-cash charges added back $400K of depreciation and amortization and $433K of share-based compensation. Working capital and other items added $3.3M. Capital expenditures of $146K left free cash flow of $217K.
Questions
What was Exagen's revenue in the fourth quarter 2024?
Exagen (XGN) reported revenue of $13.7M for the fourth quarter 2024 (Q4 2024), -0.8% from a year earlier and +9% from the quarter before.
Was Exagen profitable in the fourth quarter 2024?
Operating loss was $3.4M (-24.8% of revenue) and net loss $3.8M.
Source: Exagen 10-K on SEC EDGAR.